Recent Advances in Clinical Utility of Probiotics in Gastrointestinal Tract Disorders

Author(s): Prativa Biswasroy, Deepak Pradhan, Dipak K. Sahu, Amita Sahu, Goutam Ghosh, Goutam Rath*

Journal Name: Current Pharmaceutical Biotechnology

Volume 22 , Issue 12 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Clinically, probiotics have a significant role in nutrition, immune function, and maintenance of gut homeostasis. Unfortunately, the widespread use of antibiotics disrupts the symbiotic balance of gut microbiota, leading to the development of several gastrointestinal disorders. A recent study suggesting a combination of appropriate probiotics and prebiotics through its ability to fix dysbiosis issues has emerged as a potential alternative to treat various pathological conditions of the Gastrointestinal Tract (GIT). Evidenced-based clinical research suggests that probiotic's effectiveness depends on several factors including strain, dose, host immune system, underlying pathology, and duration of therapy. Moreover, the microflora enriched medium reinforces the host defense against chemical and microbial challenges. However, the limited information available to understand the molecular basis by which probiotic maintains the gut homeostasis. The objective of this review to emphasize recent clinical outcomes and possible mechanisms involved in probiotic action to combat the GIT disorders.

Keywords: Antibiotics, gut flora, prebiotic, clinical indications, gastrointestinal tract disease, gut-brain axis.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 22
ISSUE: 12
Year: 2021
Published on: 29 October, 2020
Page: [1559 - 1573]
Pages: 15
DOI: 10.2174/1389201021666201029154239
Price: $65

Article Metrics

PDF: 122